Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
Imeglimin lowers glucose primarily by amplifying glucose-stimulated insulin secretion in high-fat-fed rodents. [electronic resource] by
- Perry, Rachel J
- Cardone, Rebecca L
- Petersen, Max C
- Zhang, Dongyan
- Fouqueray, Pascale
- Hallakou-Bozec, Sophie
- Bolze, Sébastien
- Shulman, Gerald I
- Petersen, Kitt Falk
- Kibbey, Richard G
Producer: 20170621
In:
American journal of physiology. Endocrinology and metabolism vol. 311
Availability: No items available.
|
|
6.
|
In vitro primary human and animal cell-based blood-brain barrier models as a screening tool in drug discovery. [electronic resource] by
- Lacombe, Olivier
- Videau, Orianne
- Chevillon, Delphine
- Guyot, Anne-Cécile
- Contreras, Christelle
- Blondel, Sandrine
- Nicolas, Laurence
- Ghettas, Aurélie
- Bénech, Henri
- Thevenot, Etienne
- Pruvost, Alain
- Bolze, Sébastien
- Krzaczkowski, Lucie
- Prévost, Colette
- Mabondzo, Aloïse
Producer: 20110923
In:
Molecular pharmaceutics vol. 8
Availability: No items available.
|
|
7.
|
Imeglimin normalizes glucose tolerance and insulin sensitivity and improves mitochondrial function in liver of a high-fat, high-sucrose diet mice model. [electronic resource] by
- Vial, Guillaume
- Chauvin, Marie-Agnès
- Bendridi, Nadia
- Durand, Annie
- Meugnier, Emmanuelle
- Madec, Anne-Marie
- Bernoud-Hubac, Nathalie
- Pais de Barros, Jean-Paul
- Fontaine, Éric
- Acquaviva, Cécile
- Hallakou-Bozec, Sophie
- Bolze, Sébastien
- Vidal, Hubert
- Rieusset, Jennifer
Producer: 20150819
In:
Diabetes vol. 64
Availability: No items available.
|